TINA REED-HEARN: Open Payments
NPI 1811004914 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 57 payments from 9 companies in 2025. Trend: 2023 $980 · 2024 $1,053 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $468 |
| GlaxoSmithKline, LLC. | 13 | $183 |
| Lilly USA, LLC | 8 | $141 |
| Amgen Inc. | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $32 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, MOUNJARO, FARXIGA, OTEZLA, Kerendia, QULIPTA.
Industry payments across MS — which companies pay providers there.
